Detalhe da pesquisa
1.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Blood
; 141(8): 917-929, 2023 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36356299
2.
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.
Br J Haematol
; 204(1): 221-228, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37920129
3.
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
Eur J Haematol
; 110(2): 131-136, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36208190
4.
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.
J Thromb Thrombolysis
; 55(2): 263-272, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36484956
5.
[Interferon therapy for polycythemia vera].
Rinsho Ketsueki
; 64(10): 1290-1297, 2023.
Artigo
Japonês
| MEDLINE | ID: mdl-37914244
6.
[Novel therapeutics in myeloproliferative neoplasms: beyond JAK inhibitors].
Rinsho Ketsueki
; 64(9): 970-980, 2023.
Artigo
Japonês
| MEDLINE | ID: mdl-37793873
7.
A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms.
Jpn J Clin Oncol
; 52(8): 880-886, 2022 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35575284
8.
[Real world data on myeloproliferative neoplasms in Japan].
Rinsho Ketsueki
; 63(9): 1083-1091, 2022.
Artigo
Japonês
| MEDLINE | ID: mdl-36198533
9.
[Systemic chemotherapy combined with thrombopoietin receptor agonist for the treatment of diffuse large B-cell lymphoma complicated with aplastic anemia].
Rinsho Ketsueki
; 63(1): 20-25, 2022.
Artigo
Japonês
| MEDLINE | ID: mdl-35135947
10.
CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms.
Cancer Sci
; 112(2): 884-892, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33280191
11.
Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin.
Cancer Sci
; 111(8): 2682-2688, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32462673
12.
[Recent advances in polycythemia vera treatment].
Rinsho Ketsueki
; 61(9): 1187-1194, 2020.
Artigo
Japonês
| MEDLINE | ID: mdl-33162515
13.
Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
Eur J Haematol
; 102(6): 516-520, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30977935
14.
[Efficacy and safety of ruxolitinib in patients with myelofibrosis: a single-center retrospective analysis].
Rinsho Ketsueki
; 60(7): 755-760, 2019.
Artigo
Japonês
| MEDLINE | ID: mdl-31391362
15.
Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.
Br J Haematol
; 181(6): 791-802, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29741776
16.
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.
Blood
; 127(10): 1307-16, 2016 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-26817954
17.
The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.
Eur J Haematol
; 100(6): 544-549, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29405428
18.
[Transfusion independence achieved with pomalidomide therapy in a patient with primary myelofibrosis].
Rinsho Ketsueki
; 59(3): 323-325, 2018.
Artigo
Japonês
| MEDLINE | ID: mdl-29618692
19.
[Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].
Rinsho Ketsueki
; 58(11): 2213-2218, 2017.
Artigo
Japonês
| MEDLINE | ID: mdl-29212971
20.
[Chronic Myelomonocytic Leukemia with Myelofibrosis Resulting in Sudden Massive Pleural Effusion during Cytoreductive Therapy with Hydroxycarbamide].
Gan To Kagaku Ryoho
; 43(10): 1223-1226, 2016 Oct.
Artigo
Japonês
| MEDLINE | ID: mdl-27760943